Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10530 studies found for:    Communicable Diseases: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Communicable Diseases: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention
Conditions: Urinary Retention;   Urinary Tract Infections
Interventions: Procedure: Active Voiding Trial;   Procedure: Passive Voiding Trial
2 Active, not recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
Interventions: Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Procedure: colposcopic biopsy
3 Withdrawn Immune Response to Hepatitis C Virus
Conditions: Hepatitis C;   HIV Infections
Intervention: Other: None. Not a clinical trial. Specimens taken for basic research in laboratory.
4 Completed Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Trial)
Conditions: Nosocomial Infection;   Respiratory Tract Infection;   Surgical Site Infection
Intervention: Drug: Chlorhexidine gluconate (drug) vs placebo
5 Recruiting Cranberry Extract and Urinary Infection Prevention: a Clinical Trial
Condition: Urinary Tract Infections
Intervention: Dietary Supplement: Cranberry extract
6 Terminated Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients
Condition: Urinary Tract Infection
Interventions: Device: Silver Alloy-Coated Urinary Catheters;   Device: Conventional Urinary Catheter
7 Completed Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
Conditions: Rhinitis, Allergic, Perennial;   Hayfever;   Allergy
Intervention: Procedure: Infection with hookworm larvae
8 Completed A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection
Condition: Methicillin Resistant Staphylococcus Aureus Skin Infections
Interventions: Drug: mupirocin and chlorhexidine;   Behavioral: household cleaning and disinfection;   Drug: mupirocin, chlorhexidine, & household cleaning/disinfection
9 Completed Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
Condition: Recurrent C. Difficile Infection.
Interventions: Other: Fecal Microbiota Transplantation;   Drug: Standard Antibiotic Therapy;   Drug: Vancomycin (before randomization)
10 Completed Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)
Condition: HIV Infections
Interventions: Behavioral: Peer-driven intervention;   Behavioral: Time-matched health education
11 Recruiting The Amputation Surgical Site Infection Trial (ASSIT)
Conditions: Wound Infection;   Amputation Wound
Interventions: Drug: Co-amoxiclav;   Drug: Iodine;   Drug: Metronidazole;   Drug: Chlorhexidine;   Drug: Teicoplanin;   Drug: Clindamycin
12 Unknown  CATCH - Catheter Infections in Children
Condition: Catheter-Related Infections
Interventions: Device: Standard polyurethane Central Venous Catheter;   Device: Antibiotic impregnated polyurethane CVC (minocycline and rifampicin);   Device: Heparin bonded polyurethane CVC
13 Completed Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
Condition: HIV Infections
14 Completed Trial of Positive Deviance in Inpatient Wards to Reduce Hospital Infections
Condition: Healthcare-associated Infections
Interventions: Behavioral: Positive Deviance;   Other: Standard-of-Care Infection Control approach
15 Completed A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Condition: HIV Infections
Intervention: Other: Observation
16 Recruiting Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial
Conditions: Orthopedic Disorders;   Surgical Site Infection
Interventions: Drug: Mupirocin 2% nasal ointement;   Drug: Chlorhexidine sol 4%
17 Active, not recruiting Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV-Peptide-Specific T cells
18 Active, not recruiting Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
Condition: Malaria
Interventions: Biological: FMP012 with AS01B adjuvant system;   Other: P falciparum Controlled Human Malaria Infection (CHMI)
19 Completed Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
Conditions: HIV Infections;   Gonorrhea;   Chlamydial Infections;   Genital Herpes
Interventions: Drug: PRO 2000/5;   Drug: Placebo
20 Completed Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
Condition: HIV Infections
Intervention: Drug: didanosine + lamivudine + efavirenz

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years